Jubilant Pharmova Ltd.
🇮🇳India
- Country
- 🇮🇳India
- Ownership
- Public
- Established
- 1978-01-01
- Employees
- 5K
- Market Cap
- $1.7B
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Phase 1/2, Open-Label, Dose-Escalation Study of JI-101, in Patients With Advanced Solid Tumors
- First Posted Date
- 2009-02-12
- Last Posted Date
- 2013-06-24
- Lead Sponsor
- Jubilant Innovation Ltd.
- Target Recruit Count
- 18
- Registration Number
- NCT00842335
- Locations
- 🇺🇸
Premiere Oncology of Arizona, Scottsdale, Arizona, United States
News
Jubilant HollisterStier Launches $132 Million Sterile Injectable Manufacturing Line in Washington
Jubilant HollisterStier LLC has successfully commissioned its third sterile fill and finish line at its Spokane facility with a $132 million investment, featuring advanced isolator technology for enhanced sterility assurance.